Clinical trial
A Randomized, Double-masked, Placebo-controlled Study of the Safety of Amphotericin 0.255 μg/mL in Optisol-GS
NCT04018417 is registered in ClinicalTrials.gov with Cornea Research Foundation of America as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-masked, Placebo-controlled Study of the Safety of Amphotericin 0.255 μg/mL in Optisol-GS
- Lead sponsor
- Cornea Research Foundation of America
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- July 3, 2019
- Completion date
- July 3, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.